Inflammatory response of rapid onset asthma exacerbation;Respuesta inflamatoria de la exacerbación asmática de instauración rápida

Archivos de Bronconeumologia

Volumn 46, Issue 11, 2010, Pages 587-593

  Bellido Casado, Jesús ^a   Plaza, Vicente ^a   Perpiñá, Miguel ^b   Picado, César ^c   Bardagí, Santiago ^d   Martínez Brú, Cecilia ^e   Torrejón, Montserrat ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d HOSPITAL DE MATARÓ   (Spain)

^e UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Eosinophils; Inflammation; Neutrophils; Severe asthma exacerbation; Swelling

Indexed keywords

ALBUMIN; ELASTASE; INTERLEUKIN 8; LEUKOTRIENE E4; ALLERGEN; EOSINOPHIL CATIONIC PROTEIN; IMMUNOGLOBULIN E; PNEUMOALLERGEN; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; BLOOD EXAMINATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EOSINOPHIL; FORCED EXPIRATORY VOLUME; HUMAN; INFLAMMATION; LEUKOCYTE DIFFERENTIAL COUNT; MULTICENTER STUDY; NEUTROPHIL; PROSPECTIVE STUDY; SPUTUM EXAMINATION; URINALYSIS; ACCIDENT; ADULT; BLOOD SAMPLING; CELL COUNT; EMERGENCY WARD; EOSINOPHIL COUNT; FEMALE; FLOW RATE; INFLAMMATORY CELL; MALE; NEUTROPHIL COUNT; ONSET AGE; PATHOGENESIS; PRICK TEST; PROTEIN BLOOD LEVEL; SPUTUM ANALYSIS;

EID: 78149471312     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/S1579-2129(10)70126-9     Document Type: Article

References (41)

1. Fahy J.V., Kim K.W., Liu J., Boushey H.A. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J Allergy Clin Immunol 1995, 95:843-852.
2. Lemière C., Ernst P., Olivenstein R., Yamanuchi Y., Govindaraju K., Ludwig M.S., et al. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol 2006, 118:1033-1039.
3. Lamblin C., Gosset P., Tillie-Leblond I., Saulnier F., Marquette C.H., Wallaert B., et al. Bronchial neutrophilia in patients with Noninfectious status asthmaticus. Am J Respir Crit Care Med 1998, 157:394-402.
4. Sur S., Crotty T.B., Kephart G.M., Hyma B.A., Colby T.V., Reed C.E., et al. Sudden-onset fatal asthma: a distinct entity with few eosinophils and relatively more neutrophils in the airway submucosa?. Am Rev Respir Dis 1993, 148:713-719.
5. Plaza V., Serrano J., Picado C., Sanchis J. On behalf of the High Risk Asthma Research Group. Rapid-Onset Fatal and Near-fatal Asthma. Frequency, Clinical Characteristics and Course. Eur Respir J 2002, 19:846-852.
6. Wasserfallen J.B., Schaller M.D., Feihl F., Perret C.H. Sudden asphyxic asthma: a distinct entity?. Am Rev Respir Dis 1990, 142:108-111.
7. Hargreave F.E., Nair P. The definition and diagnosis of asthma. Clin Exp Allergy 2009 2009, 39:1652-1658.
8. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. Eur Respir J 2003, 22:470-477. The ENFUMOSA Study Group.
9. Macedo P., Hew M., Torrego A., Jouneau S., Oates T., Durham A., et al. Inflammatory biomarkers in airways of patients with severe asthma compared with non-severe asthma. Clin Exp Allergy 2009, 39:1668-1676.
10. Berry M., Morgan A., Shaw D.E., Parker D., Green R., Brightling C., et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007, 62:1043-1049.
11. Saha S., Berry M.A., Parker D., Siddiqui S., Morgan A., May R., et al. Increased sputum and bronchial biopsy IL-13 expresssion in severe asthma. J Allergy Clin Immunol 2008, 121:685-691.
12. Bellido-Casado J, Plaza V, Belda J, Martínez-Brú C, Torrejón M, Sanchis J. Swelling of the bronchial mucose and quickness of onset in acute asthma. Med Clin (Barc);127:451-3.
13. Tillie-Leblond I., Gosset P., Tonnel A.B. Inflammatory events in sever acute asthma. Allergy 2005, 60:23-29.
14. Plaza Moral V., Álvarez Gutiérrez F.J., Casan Clarà P., Cobos Barroso N., López Viña A., Llauger Rosselló M.A., et al. Guía Española para el Manejo del Asma (GEMA). Arch Bronconeumol 2003, 39(Supl5):1-42. en calidad de Comité Ejecutivo de la GEMA y en representación del grupo de redactores.
15. Pizzichini E., Pizzichini M.M., Efthimiadis A., Evans S., Morris M.M., Squillace D., et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996, 154:308-317.
16. Barberá JA, Giner J, Casan P, Burgos F. Gasometría arterial. En Procedimientos de evaluación de la Función Pulmonar. Manual SEPAR de procedimientos. Ed SEPAR 2002.
17. Norzila M.Z., Fakes K., Hernry R.L., Simpson J., Gibson P.G. Interleukin-8 secretion and neutrophil recruitment accompanies induced sputum eosinophil activation in children with acute asthma. Am J Respir Crit Care Med 2000, 161:769-774.
18. D'Silva L., Allen C.J., Hargreave F.E., Parameswaran K. Sputum neutrophilia can mask eosinophilic bronchitis during exacerbations. Can Respir J 2007, 14:281-284.
19. D'Silva L., Cook R.J., Allen C.J., Hargreave F.E., Parameswaran K. Changing pattern of sputum cell counts during successive exacerbations of airway disease. Respir Med 2007, 101:2217-2220.
20. Gibson P.G., Norzila M.Z., Fakes K., Simpson J., Henry R.L. Pattern of airway inflammation and its determinants in children with acute severe asthma. Pediatr Pulmonol 1999, 28:261-270.
21. Khor Y.H., Teoh A.K.Y., Lam S.M., Mo D.C.Q., Weston S., Reid D.W., et al. Increased vascular permeability precedes cellular inflammation as asthma control deteriorates. Clin Exp Allergy 2009, 39:1659-1667.
22. Lampinen M., Carlson M., Hakansson L.D., Venge P. Cytokine-regulated accumulation of eosinophils in inflammatory disease. Allergy 2004, 59:793-805.
23. Hiraguchi Y., Nagao M., Hosoki K., Tokuda R., Fujisawa T. Neutrophil proteases activate eosinophil function in vitro. Int Arch Allergy Immunol 2008, 146(suppl 1):16-21.
24. Gorska K., Krenke R., Domagala-Kulawik J., Korczynski P., Nejman-Gryz P., Kosciuch J., et al. Comparison of cellular and biochemical markers or airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study. J Physiol Pharmacol 2008, 59(suppl 6):271-283.
25. Zhang J.Y., Wenzel S.E. Tissue and BAL based biomarkers in asthma. Immunol Allergy Clin N Am 2007, 27:623-632.
26. Koh G.C.-H., Shek L.P.-C., Goh D.Y.-T., Van Bever H., Koh D.S.-Q. Eosinophil cationic protein: is it useful in asthma? A systematic review. Respir Med 2007, 101:696-705.
27. Rabinovitch N. Urinary leukotriene. Immunol Allergy Clin N Am 2007, 27:651-664.
28. Romagnoli M., Vachier I., Tarodo de la Fuente P., Meziane H., Chavis C., Bousquet J., et al. Eosinophilic inflammation in sputum of poorly controlled asthmatics. Eur Respir J 2002, 20:1370-1377.
29. Shannon J., Ernst P., Yamanuchi Y., Olivenstein R., Lemiere C., Foley S., et al. Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest 2008, 133:420-426.
30. Spahn J.D. Asthma biomarkers in sputum. Immunol Allergy Clin N Am 2007, 27:607-622.
31. Bartoli M.L., Di Franco A., Vagaggini B., Bacci E., Cianchetti S., Dente F.L., et al. Biological markers in induced sputum of patients with different phenotypes of chronic airway obstruction. Respiration 2009, 77:265-272.
32. Silvestri M., Bontempelli M., Giacomelli M., Malerba M., Rossi G.A., Di Stefano A., et al. High serum levels of tumor necrosis factor-α and interlekin-8 in severe asthma: markers of systemic inflammation?. Clin Exp Allergy 2006, 36:1373-1381.
33. Tsoumakidou M., Papadopouli E., Tzanakis N., Siafakas N. Airway inflammation and cellular stress in noneosinophilic atopic asthma. Chest 2006, 129:1194-1202.
34. Dente F.L., Carnevali S., Bartoli M.L., Cianchetti S., Bacci E., Di Franco A., et al. Profiles of proinflammatory cytokines in sputum from different groups of severe asthmatic patients. Ann Allergy Asthma Immunol 2006, 97:312-320.
35. Higashimoto Y., Yamagata Y., Taya S., Iwata T., Okada M., Ishiguchi T., et al. Systemic inflammation in chronic obstructive pulmonary disease and asthma: similarities and differences. Respirology 2008, 13:128-133.
36. 4 levels are associated with decreased pulmonary function in children with persistent airway obstruction. J Allergy Clin Immunol 2006, 118:635-640.
37. Papadopouli E., Tzanakis N., Tsoumakidou M., Kyriakoy D., Plataki M., Mantzouranis E.C., et al. Comparison of induced sputum inflammatory profiles between childhood and adult-onset asthma. Respir Med 2006, 100:1442-1450.
38. St-Laurent, Bergeron C., Pagé N., Couture C., Laviolette M., Boulet L.P. Influence of smoking on airway inflammation and remodelling in asthma. Clin Exp Allergy 2008, 38:1582-1589.
39. Claman D.M., Boushey H.A., Liu J., Wong H., Fahy J.V. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol 1994, 94:861-869.
40. Keatings V.M., Jatakanon A., Worsdell Y.M., Barnes P.J. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997, 155:542-548.
41. Chalmers G.W., MacLeod K.J., Thomson L., Little S.A., McSharry C., Thomson N.C. Smoking and airway inflammation in patients with mild asthma. Chest 2001, 120:1917-1922.